Pond Technologies Announces Grant of Stock Options
Pond Technologies Holdings Inc. announced the grant of 1,495,000 stock options to eligible executives, employees, and consultants on March 31, 2021. Each option is exercisable for one common share at an exercise price of $0.62, matching the closing price on March 30, 2021. The options will vest in three phases over three years: one-third immediately, another third after one year, and the final third after two years. Pond Technologies, based in Ontario, focuses on sustainable solutions utilizing micro-algae technology for various industries including pharmaceuticals, cosmetics, and bioplastics.
- Granting of 1,495,000 stock options could incentivize executives and employees, potentially aligning their interests with shareholders.
- Pond's technology in micro-algae could lead to multiple revenue streams through licensing and royalties.
- The company's focus on sustainability and innovation positions it well in growing markets such as pharmaceuticals and bioplastics.
- The stock options may dilute existing shareholder value if exercised, depending on the number of options exercised.
MARKHAM, ON / ACCESSWIRE / April 1, 2021 / Pond Technologies Holdings Inc. ("Pond") (TSX.V:POND); (OTCQB:PNDHF); (FSE:400), an ESG company addressing global sustainability challenges of wellness and climate change announces that on March 31, 2021 it granted an aggregate of 1,495,000, stock options (the "Options") to eligible executives, employees and consultants under the Corporation's existing stock option plan. Each Option is exercisable for one common share of the Corporation at an exercise price of
About Pond Technologies Holdings Inc.:
Located in Markham, Ontario, Pond Technology is a technology leader in controlled environment cultivation of micro-algae. In over ten years of R&D, Pond has developed a robust disruptive technology platform based on artificial intelligence, proprietary LED-lights and patented CO2-Management. The use of concentrated CO2 from industrial waste streams enables Pond to boost productivity of micro-algae well beyond the capacity of outdoor algae growers and allows industrial emitters to abate and ultimately recycle CO2. Pond is currently selling micro-algae derived antioxidant Astaxanthin under its Regenurex brand. As micro-algae are becoming increasingly important in pharmaceuticals and cosmetics, nutraceuticals, human nutrition, aqua farming, bioplastics and biofuels, Pond has begun to license its technology to third parties for ongoing license fees and royalties. Pond recently added a Biotech division focused on the growth of unique strains of micro-algae to be used as a reproductive medium for the expression of human anti-bodies and proteins.
For more information, please visit https://www.pondtech.com/.
Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.
For further information contact: Grant Smith, Chief Executive Officer, at g.smith@pondtech.com, 416-287-3835 ext. 201; or Chris Cory at c.cory@pondtech.com , 416-287-3835 ext. 215.
SOURCE: Pond Technologies Holdings Inc.
View source version on accesswire.com:
https://www.accesswire.com/638602/Pond-Technologies-Announces-Grant-of-Stock-Options
FAQ
What are the details of the stock options granted by Pond Technologies on March 31, 2021?
What is the significance of the stock option grant for Pond Technologies shareholders?
How does Pond Technologies plan to use its micro-algae technology?
What is the current stock price of Pond Technologies as of March 30, 2021?